| Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy YC Wang, X Wang, J Yu, F Ma, Z Li, Y Zhou, S Zeng, X Ma, YR Li, A Neal, ... Nature communications 12 (1), 3530, 2021 | 117 | 2021 |
| Creatine uptake regulates CD8 T cell antitumor immunity S Di Biase, X Ma, X Wang, J Yu, YC Wang, DJ Smith, Y Zhou, Z Li, YJ Kim, ... Journal of Experimental Medicine 216 (12), 2869-2882, 2019 | 106 | 2019 |
| Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy YR Li, Y Zhou, YJ Kim, Y Zhu, F Ma, J Yu, YC Wang, X Chen, Z Li, S Zeng, ... Cell Reports Medicine 2 (11), 2021 | 79 | 2021 |
| Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules MT Bethune, XH Li, J Yu, J McLaughlin, D Cheng, C Mathis, BH Moreno, ... Proceedings of the National Academy of Sciences 115 (45), E10702-E10711, 2018 | 78 | 2018 |
| Development of hematopoietic stem cell-engineered invariant natural killer T cell therapy for cancer Y Zhu, DJ Smith, Y Zhou, YR Li, J Yu, D Lee, YC Wang, S Di Biase, ... Cell Stem Cell 25 (4), 542-557. e9, 2019 | 75 | 2019 |
| Targeting monoamine oxidase A for T cell–based cancer immunotherapy X Wang, B Li, YJ Kim, YC Wang, Z Li, J Yu, S Zeng, X Ma, IY Choi, ... Science immunology 6 (59), eabh2383, 2021 | 53 | 2021 |
| Ophiocordyceps lanpingensis polysaccharides attenuate pulmonary fibrosis in mice S Zhou, Y Zhou, J Yu, Y Du, Y Tan, Y Ke, J Wang, B Han, F Ge Biomedicine & Pharmacotherapy 126, 110058, 2020 | 24 | 2020 |
| Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention YR Li, ZS Dunn, G Garcia Jr, C Carmona, Y Zhou, D Lee, J Yu, J Huang, ... Stem cell research & therapy 13 (1), 112, 2022 | 23 | 2022 |
| Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers YR Li, S Zeng, ZS Dunn, Y Zhou, Z Li, J Yu, YC Wang, J Ku, N Cook, ... Iscience 25 (9), 2022 | 18 | 2022 |
| Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method YR Li, Y Zhou, J Yu, YJ Kim, M Li, D Lee, K Zhou, Y Chen, Y Zhu, ... Nature Biotechnology, 1-16, 2024 | 17 | 2024 |
| Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy YR Li, Y Zhou, J Yu, Y Zhu, D Lee, E Zhu, Z Li, YJ Kim, K Zhou, Y Fang, ... Molecular Therapy 32 (6), 1849-1874, 2024 | 13 | 2024 |
| A neutral polysaccharide from Ophiocordyceps lanpingensis restrains cisplatin‐induced nephrotoxicity S Zhou, Y Zhou, J Yu, L Jiang, Y Xiang, J Wang, Y Du, X Cui, F Ge Food Science & Nutrition 9 (7), 3602-3616, 2021 | 10 | 2021 |
| Bubble-mediated large-scale hierarchical assembly of ultrathin Pt nanowire network monolayer at gas/liquid interfaces E Zhu, Y Liu, J Huang, A Zhang, B Peng, Z Liu, H Liu, J Yu, YR Li, L Yang, ... ACS nano 17 (14), 14152-14160, 2023 | 6 | 2023 |
| Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies E Zhu, J Yu, YR Li, F Ma, YC Wang, Y Liu, M Li, YJ Kim, Y Zhu, Z Hahn, ... Nature Nanotechnology 19 (12), 1914-1922, 2024 | | 2024 |
| T Cell Receptor Gene Engineered Cell Therapy for Cancer J Yu eScholarship, University of California, 2021 | | 2021 |
Michael T. BethuneCalifornia Institute of TechnologyVerified email at caltech.edu